Literature DB >> 12079488

Ecdysone-controlled expression of transgenes.

Lloyd D Graham1.   

Abstract

Inducible expression systems show great potential for use in human gene therapy and systems based on insect ecdysone receptors are particularly promising candidates. This article describes such systems and reviews actual and potential uses of ecdysone-controlled transgenes in vitro and in vivo. The ligand specificity of ecdysone receptor-based systems is considered, along with the safety and efficacy of the ecdysteroid and non-steroidal compounds used to activate them.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079488     DOI: 10.1517/14712598.2.5.525

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  5 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

Review 2.  Potential therapeutic uses of BDNF in neurological and psychiatric disorders.

Authors:  Alan H Nagahara; Mark H Tuszynski
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

3.  Superimposition evaluation of ecdysteroid agonist chemotypes through multidimensional QSAR.

Authors:  Robert E Hormann; Laurence Dinan; Pensri Whiting
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

4.  Novel ecdysteroids from Serratula wolffii.

Authors:  Attila Ványolós; Zoltán Béni; Miklós Dékány; András Simon; Mária Báthori
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 5.  Practical uses for ecdysteroids in mammals including humans: an update.

Authors:  R Lafont; L Dinan
Journal:  J Insect Sci       Date:  2003       Impact factor: 1.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.